Development of a Method to Evaluate the Release Profile of Tamoxifen from Pegylated Hybrid Micelles

References

• Brasil. Ministério da Saúde. Instituto Nacional do Câncer, 2013. Tipos de câncer–mama. http://www2.inca.gov.br/wps/wcm/connect/tiposdecancer/site/home/mama (accessed Jan., 2013).
   Google Scholar
• Anderson, G. F.; Chu, E. Expanding Priorities-confronting Chronic Disease in Countries with Low Income. New Engl. J. Med. 2007, 356, 209.
   PubMed Web of Science ®Google Scholar
• Goss, P. E. Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-positive Breast Cancer: Update Findings from NCIC CTG MA.17. J. Natl. Cancer I. 2005, 97, 1262.
   PubMed Web of Science ®Google Scholar
• Antunes, M. V.; Raymundo, S.; Oliveira, V.; Staudt, D. E.; Gössling, G.; Peteffi, G. P.; Biazús, J. V.; Cavalheiro, J. A.; Tre-Hardy, M.; Capron, A.; Haufroid, V.; Wallemacq, P.; Schwartsmann, G.; Linden, R. Ultra-high Performance Liquid Chromatography Tandem Mass Spectrometric Method for the Determination of Tamoxifen, N-Desmethyltamoxifen, 4-Hydroxytamoxifen and Endoxifen in Dried Blood Spots - Development, Validation and Clinical Application During Breast Cancer Adjuvant Therapy. Talanta, 2015, 132, 775.
   PubMed Web of Science ®Google Scholar
• Tanaka, T.; Decuzzi, P.; Cristofanilli, M.; Sakamoto, J. H.; Tasciotti, E.; Robertson, F. K.; Ferrari, M. Nanotechnology for Breast Cancer Therapy. Biomed. Microdevices 2009, 11, 49.
   PubMed Web of Science ®Google Scholar
• O’Regan, R. M.; Jordan, V. C. The Evolution of Tamoxifen Therapy in Breast Cancer: Selective Oestrogenic-receptor Modulators and Down-regulators. Lancet Oncol. 2002, 3, 207.
   PubMed Web of Science ®Google Scholar
• De Lima, G. R.; Facina, G.; Shida, J. Y.; Chein, M. B. C.; Tanaka, P.; Dardes, R. C.; Jordan, V. C.; Gebrim, L. H. Effects of Low Dose Tamoxifen on Normal Breast Tissue from Premenopausal Women. Eur. J. Cancer 2003, 39, 891.
   PubMed Web of Science ®Google Scholar
• Neven, P.; Vergote, I. Tamoxifen, Screening and New Oestrogen Receptor Modulators. Best Pract. Res. Cl. Ob. 2001, 15, 365.
   Web of Science ®Google Scholar
• Vosse, M.; Renard, F.; Coibion, M.; Neven, P.; Nogaret, J. M.; Hertens, D. Endometrial Disorders in 406 Breast Cancer Patients on Tamoxifen: The Case for Less Intensive Monitoring. Eur. J. Obstet. Gynaecol. Reprod. Biol. 2002, 101, 58.
   PubMed Web of Science ®Google Scholar
• Cohen, I. Endometrial Pathologies Associated with Postmenopausal Tamoxifen Treatment. Gynecol. Oncol. 2004, 94, 256.
   PubMed Web of Science ®Google Scholar
• Martínez, A.; Muñiz, E.; Iglesias, I.; Teijón, J. M.; Blanco, M. D. Enhanced Preclinical Efficacy of Tamoxifen Developed as Alginate–cysteine/Disulfide Bond Reduced Albumin Nanoparticles. Int. J. Pharm. 2012, 436, 574.
   PubMed Web of Science ®Google Scholar
• Peyrade, F.; Frenay, M.; Etienne, M. C.; Ruch, F.; Guillermare, C.; François, E.; Namer, M.; Ferrero, J. M.; Milano, G. Age-related Difference in Tamoxifen Disposition. Clin. Pharmacol. Ther. 1996, 59, 401.
   PubMed Web of Science ®Google Scholar
• Pandey, S. K.; Ghosha, S.; Maiti, P.; Haldar, C. Therapeutic Efficacy and Toxicity of Tamoxifen Loaded PLA Nanoparticles for Breast Cancer. Int. J. Biol. Macromol. 2015, 72, 309.
   PubMed Web of Science ®Google Scholar
• Orive, G.; Hernández, R. M.; Gascón, A. R.; Pedraz, J. L. Micro and Nano Drug Delivery Systems in Cancer Therapy. Cancer Ther. 2005, 3, 131.
   Google Scholar
• Aulton, M. E. Delineamento de Formas Farmacêuticas. 2ª ed., Porto Alegre: Artmed, 2005; 677 p.
   Google Scholar
• Torchilin, V. P. PEG-based Micelles as Carriers of Contrast Agents for Different Imaging Modalities. Adv. Drug Del. Rev. 2002, 54, 235.
   PubMed Web of Science ®Google Scholar
• Satoh, T.; Higuchi, Y.; Kawakami, S.; Hashida, M.; Kagechika, H.; Shudo, K.; Yokoyama, M. Encapsulation of Synthetic Retinoids Am80 and LE540 into Polymeric Micelles and the Retinoids’ Release Control. J. Control. Release 2009, 136, 187.
   PubMed Web of Science ®Google Scholar
• Matsumara, Y.; Maeda, H. A New Concept for Macromolecular Therapeutics in Cancer Chemotherapy: Mechanism of Tumoritropic Accumulation of Proteins and the Antitumor Agent SMANCS. Cancer Res. 1986, 46, 6387.
   PubMed Web of Science ®Google Scholar
• Maeda, H.; Wu, J.; Sawa, T.; Matsumura, Y.; Hori, K. Tumor Vascular Permeability and the EPR Effect in Macromolecular Therapeutics: A Review. J. Control. Release 2000, 65, 271.
   PubMed Web of Science ®Google Scholar
• Ashok, B.; Arleth, L.; Hjelm, R. P.; Rubinstein, I.; Önyüksel, H. In vitro Characterization of Pegylated Phospholipid Micelles for Improved Drug Solubilization: Effects of PEG Chain Length and PC Incorporation. J. Pharm. Sci. 2004, 93, 2476.
   PubMed Web of Science ®Google Scholar
• Working, P. K.; Dayan, A. D. Pharmacological – Toxicological Expert Report – CAELYX (Stealth Liposomal Doxorubicin HCl). Hum. Exp. Toxicol. 1996, 15, 751.
   PubMed Web of Science ®Google Scholar
• Allen, C.; Dos Santos, N.; Gallagher, R.; Chiu, G. N. C.; Shu, Y.; Li, W. M.; Johnstone, S. A.; Janoff, A. S.; Mayer, L. D.; Webb, M. S.; Bally, M. B. Controlling the Physical Behavior and Biological Performance of Liposome Formulations Use of Surface Grafted Poly(ethylene glycol). Biosci. Rep. 2002, 22, 225.
   PubMed Web of Science ®Google Scholar
• Carstens, M. G.; Rijcken, C. J. F.; Van Nostrum, C. F.; Hennink, W. E. Pharmaceutical Micelles: Combining Longevity, Stability and Stimuli Sensitivity. In Multifunctional Pharmaceutical Nanocarriers; Torchilin, V. P., Ed.; Springer: New York, 2008; chap. 2. (Fundamental Biomedical Technologies, v. 4).
   Google Scholar
• Owens, D. E.; Peppas, N. A. Opsonization, Biodistribution, and Pharmacokinetics of Polymeric Nanoparticles. Int. J. Pharm. 2006, 307, 93.
   PubMed Web of Science ®Google Scholar
• Stolnik, S.; Illum, L.; Davis, S. S. Long Circulating Microparticulate Drug Carriers. Adv. Drug Del. Rev. 1995, 16, 195.
   Web of Science ®Google Scholar
• Sawant, R. R.; Sawant, R. M.; Torchilin, V. P. Mixed PEG–PE/vitamin E Tumor-targeted Immunomicelles as Carriers for Poorly Soluble Anti-cancer Drugs: Improved Drug Solubilization and Enhanced In vitro Cytotoxicity. Eur. J. Pharmaceut. Biopharmaceut. 2008, 70, 51.
   PubMed Web of Science ®Google Scholar
• Haeri, A.; Sadeghian, S.; Rabbani, S.; Anvari, M. S.; Lavasanifar, A.; Amini, M.; Dadashzadeh, S. Sirolimus-loaded Stealth Colloidal Systems Attenuate Neointimal Hyperplasia After Balloon Injury: A Comparison of Phospholipid Micelles and Liposomes. Int. J. Pharm. 2013, 455, 320.
   PubMed Web of Science ®Google Scholar
• Sadoqi, M.; Lau-Cam, C. A.; Wu, S. H. Investigation of the Micellar Properties of the Tocopheryl Polyethylene Glycol Succinate Surfactants TPGS 400 and TPGS 1000 by Steady State Fluorometry. J. Colloid Interf. Sci. 2009, 333, 585.
   PubMed Web of Science ®Google Scholar
• Mu, L.; Elbayoumi, T. A.; Torchilin, V. P. Mixed Micelles Made of Poly(ethylene glycol)–phosphatidylethanolamine Conjugate and d-α -tocopheryl Polyethylene Glycol 1000 Succinate as Pharmaceutical Nanocarriers for Camptothecin. Int. J. Pharm. 2005, 306, 142.
   PubMed Web of Science ®Google Scholar
• Gordon, L. A.; Lennernäs, H.; Shah, V. P.; Crison, J. R. A Theoretical Basis for Biopharmaceutic Drug Classification: The Correlation of In vitro Drug Product Dissolution and In vivo Bioavailability. Pharm. Res. 1995, 12, 413.
   PubMed Web of Science ®Google Scholar
• Laraus, J.; Cooper, J. Absorption, Testing and Clinical Evaluation of Oral Prolonged Action Drug. J. Pharm. Sci. 1961, 50, 215.
   Google Scholar
• Jain, R.; Jain, N.; Jain, D. K.; Patel, V. K.; Rajak, H.; Jain, S. K. Novel UV Spectrophotometer Methods for Quantitative Estimation of Metronidazole and Furazolidone Using Mixed Hydrotropy Solubilization. Arabian J. Chem. 2013, In press, http://dx.doi.org/10.1016/j.arabjc.2013.09.003.
   Google Scholar
• Cho, Y. W.; Lee, J.; Lee, S. C.; Huh, K. M.; Park, K. Hydrotropic Agents for Study of In vitro Paclitaxel Release from Polymeric Micelles. J. Control. Release 2004, 97, 249.
   PubMed Web of Science ®Google Scholar
• Brasil. Ministério da Saúde. Agência Nacional de Vigilância Sanitária, 2003. Resolução RES 899, de 29 de maio de 2003. Guia para validação de métodos analíticos e bioanalíticos.
   Google Scholar
• Ribeiro, F. A. L.; Ferreira, M. M. C.; Morano, S. C.; Silva, L. R.; Schneider, R. P. Planilha de validação: uma nova ferramenta para estimar figuras de mérito na validação de métodos analíticos univariados. Quim. Nova, 2008, 1, 164.
   Web of Science ®Google Scholar
• Chiaradia, M. C. Desenvolvimento, validação e aplicação de métodos para análise multirresidual de agrotóxicos em suco de laranja e tangerina utilizando CLAE-DAD, CL-EM-EM e CLUE-DAD, 2009. Thesis (Doctoral). Instituto de Química, Universidade Estadual de Campinas, Campinas. 119 p.
   Google Scholar
• International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), 2005. ICH Harmonised Tripartite Guideline. Validation of analytical procedures: text and methodology Q2(R1). Current Step 4 version.
   Google Scholar
• Brasil. Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO), 2010. Orientação sobre validação de métodos analíticos - DOQ-CGCRE-008, revision 03.
   Google Scholar
• Lavasanifar, A.; Samuel, J.; Kwon, G. S. Micelles Self-assembled from Poly(ethylene oxide)-block-poly(N-hexyl Stearate L-aspartamide) by a Solvent Evaporation Method: Effect on the Solubilization and Haemolytic Activity of Amphotericin B. J. Control. Rel. 2001, 77, 155.
   PubMed Web of Science ®Google Scholar
• Lukyanov, A. N.; Gao, Z.; Torchilin, V. P. Micelles from Polyethylene Glycol/phosphatidylethanolamine Conjugates for Tumor Drug Delivery. J. Control. Rel. 2003, 91, 97.
   PubMed Web of Science ®Google Scholar
• Lukyanov, A. N.; Torchilin, V. P. Micelles from Lipid Derivatives of Water-soluble Polymers as Delivery Systems for Poorly Soluble Drugs. Adv. Drug Del. Rev. 2004, 56, 1273.
   PubMed Web of Science ®Google Scholar
• Sawant, R. R.; Torchilin, V. P. Enhanced Cytotoxicity of TATp-bearing Paclitaxel-loaded Micelles In vitro and In vivo. Int. J. Pharm. 2009, 374, 114.
   PubMed Web of Science ®Google Scholar
• Chawla, J. S.; Amiji, M. M. Biodegradable Poly(epsilon-caprolactone) Nanoparticles for Tumor-targeted Delivery of Tamoxifen. Int. J. Pharm. 2002, 249, 127.
   PubMed Web of Science ®Google Scholar
• MacCallum, J.; Cummings, J.; Dixon, J. M.; Miller, W. R. Solid-phase Extraction and High-performance Liquid Chromatographic Determination of Tamoxifen and Its Major Metabolites in Plasma. J. Chromatogr. B 1996, 678, 317.
   PubMed Web of Science ®Google Scholar